Mr. Patrick BOISSEAU is a graduate of the Institut National Agronomique (1983) and of the Ecole Nationale du Génie Rural, des Eaux et des Forêts (1985). He holds an MSc Degree in Human Nutrition. His general academic background is therefore in biology engineering.
To date, about 40 nanomedicines have been approved by the U.S. Food and Drug Administration and about 20 by the European Medicines Agency, says Patrick Boisseau, nanomedicine program manager at the French Atomic Energy Commission and chairman of European Technology Platform on Nanomedicine. A further 130 nanomedicines are in clinical trials. It can take more than a decade for a drug, including nanomedicines, to receive regulatory approval.
Patrick Boisseau coordinates and/or participates to numerous French and European funded research projects in nanobiotech and nanomedicine.
Patrick Boisseau serves as expert or reviewer for several national/European bodies: European Commission, European Science Foundation, the European Commission, Oesterreichische Forschungsfoerderungsgesellschaft GmbH (AT), Agence Nationale de la Recherche (FR), EuroNanoMed (EU), CIBER-BBN (ES)…
|1. LIVING (RIN: 10537)|
|2. Nancy Carter BOISSEAU (RIN: 10538), b. 11 November 1836|
|3. Susan Elizabeth BOISSEAU (RIN: 10539), b. 31 May 1839|
|4. LIVING (RIN: 10540)|
|5. LIVING (RIN: 10541)|
|6. Patrick BOISSEAU (RIN: 10542)|